93 related articles for article (PubMed ID: 21141077)
1. [Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration].
Kawase K; Yamamoto T; Muramatsu T; Ono J; Nakajima T; Matsuhisa A; Sugiura T; Migita M; Ishikawa Y
Nippon Ganka Gakkai Zasshi; 2010 Nov; 114(11):976-82. PubMed ID: 21141077
[TBL] [Abstract][Full Text] [Related]
2. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
Yamamoto T;
Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
[TBL] [Abstract][Full Text] [Related]
5. Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients.
Renard P; Kovalski JL; Cochereau I; Jaulerry S; Williamson W; Elena PP; Lablache Combier M; Allaire C; Siou-Mermet R
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1221-7. PubMed ID: 16003515
[TBL] [Abstract][Full Text] [Related]
6. Ocular hypotensive efficacy and safety of once daily carteolol alginate.
Demailly P; Allaire C; Trinquand C;
Br J Ophthalmol; 2001 Aug; 85(8):921-4. PubMed ID: 11466245
[TBL] [Abstract][Full Text] [Related]
7. Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma.
Nakamoto K; Yasuda N
Jpn J Ophthalmol; 2010 Mar; 54(2):140-3. PubMed ID: 20401563
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
[TBL] [Abstract][Full Text] [Related]
9. Carteolol: preliminary study on ocular pressure-reducing action.
Gorgone G; Spina F; Amantia L
Ophthalmologica; 1983; 187(3):171-3. PubMed ID: 6355953
[TBL] [Abstract][Full Text] [Related]
10. Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma.
Ikeda Y; Mori K; Ishibashi T; Naruse S; Nakajima N; Kinoshita S
J Ocul Pharmacol Ther; 2008 Apr; 24(2):230-4. PubMed ID: 18341431
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
Ishii Y; Nakamura K; Matsuki S; Uemura N; Muraguchi R; Nakagawa M; Nakano S; Nakatsuka K
J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.
Stewart WC; Leland TM; Cate EA; Stewart JA
J Glaucoma; 1998 Dec; 7(6):402-7. PubMed ID: 9871862
[TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
[TBL] [Abstract][Full Text] [Related]
15. [Effect of 0.004% travoprost and 2% carteolol on intraocular pressure in patients with ocular hypertension after laser peripheral iridotomy or trabeculectomy in primary angle-closure glaucoma].
Yao BQ; Pang YY; Li YX
Zhonghua Yan Ke Za Zhi; 2013 Apr; 49(4):340-4. PubMed ID: 23900094
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol.
Behrens-Baumann W; Kimmich F; Walt JG; Lue J
Ophthalmologica; 1994; 208(1):32-6. PubMed ID: 8145982
[TBL] [Abstract][Full Text] [Related]
17. Effect of topical beta-blockers on tissue blood flow in the human optic nerve head.
Tamaki Y; Araie M; Tomita K; Nagahara M; Tomidokoro A
Curr Eye Res; 1997 Nov; 16(11):1102-10. PubMed ID: 9395769
[TBL] [Abstract][Full Text] [Related]
18. [Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
Schnarr KD
Klin Monbl Augenheilkd; 1988 Feb; 192(2):167-72. PubMed ID: 2896266
[TBL] [Abstract][Full Text] [Related]
19. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
[TBL] [Abstract][Full Text] [Related]
20. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
Gandolfi SA; Vecchi M
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
